RESPONSE OF RENAL CELLS IN INTERSTITIAL NEPHRITIS
间质性肾炎中肾细胞的反应
基本信息
- 批准号:2145463
- 负责人:
- 金额:$ 17.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1993
- 资助国家:美国
- 起止时间:1993-05-01 至 1998-04-30
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting angiotensin II antisense nucleic acid autoimmune disorder basement membrane chimeric proteins collagen epithelium fibroblasts gene expression histocompatibility gene inflammation interstitial nephritis kidney cell kidney hypertrophy laboratory mouse membrane reconstitution /synthesis molecular cloning radioimmunoassay renal tubule reporter genes transfection
项目摘要
DESCRIPTION (Adapted from investigator's abstract): The appearance of
interstitial nephritis is an expected development in the natural history
of all forms of progressive renal failure. The investigators have been
studying this inflammatory process using an experimental model of
immune-mediated interstitial nephritis in mice called anti-tubular
basement membrane (alphaTBM) disease. Primary immune injury is produced
in this model by T cells and antibodies (alphaTMB-Ab/alpha3M-1-Ab) which
are directed at a tubular target antigen (3M-1) expressed by proximal
tubular epithelium. Histologic damage occurs through the formation of
interstitial mononuclear cell infiltrates that subsequently invoke a
progressive fibrogenesis with tubular atrophy. The emergence of this
autoimmune process rendering structural damage is a product of complex
biochemical events that depend on two interactive components; one
component is the development of a destructive nephritogenic immune
response. The other component is the reaction of the tubulo-
interstitium to mononuclear intrusion. The long term purpose and goals
of this application have been focused on the latter issue.
In their current renewal they have concentrated selectively on several
fundamental, inflammation-relevant protein systems which modulate the
immunologic visibility, tissue boundaries, cell size, and phenotype of
target tubular epithelium and their associated fibroblasts. Over the
course of the last few years their work can be distilled down and
tracked into four critical areas: one area has been to determine how
MHC class II genes are regulated in tubular epithelium; the second area
has been to determine how type IV collagen genes are modulated during
basement membrane remodelling; the third area has been to understand the
molecular mechanisms of tubular hypertrophy and how cellular enlargement
may influence the expression of nephritogenic antigens; and the fourth
area has been to develop antibodies and molecular probes which can be
used specifically to identify tubulo-interstitial fibroblasts. These
four project themes collectively bridge the disciplines of genetics and
biochemistry with basic pathophysiology in order to better discern major
processes leading to aberrant structural change in interstitial tissue.
The investigators' experiments rely on both in vitro and in vivo
technologies in order to assemble a comprehensive database on this
subject; these technologies include the use of cell culture,
radioimmunoassay, cDNA cloning, chimeric reporter gene constructs, gel
retardation assays, DNA footprinting, transgene replacement, eurkaryotic
transfection, and antisense inhibition. They believe their approach and
the level of their analysis will lead to a better comprehension of
critical somatic cell responses to immune events that may offer new
insights regarding the formation of rational strategies for improved
treatment of interstitial injury.
描述(改编自研究者摘要):
间质性肾炎是自然病程中的一种预期发展
各种形式的进行性肾衰竭 调查人员一直在
研究这种炎症过程的实验模型,
免疫介导的小鼠间质性肾炎称为抗肾小管
基底膜(alphaTBM)疾病。 产生原发性免疫损伤
在该模型中,通过T细胞和抗体(α TMB-Ab/α 3 M-1-Ab),
针对由近端表达的肾小管靶抗原(3 M-1),
肾小管上皮 组织学损伤是通过形成
间质单核细胞浸润,随后引起
进行性纤维化伴肾小管萎缩。 出现这种
自身免疫过程导致结构损伤是一种复杂的
生物化学事件取决于两个相互作用的成分;一个
组成部分是一种破坏性的致肾炎免疫的发展
反应 另一个成分是微管的反应-
氚到单核侵入。 长期目的和目标
本申请的重点是后一个问题。
在目前的更新中,他们有选择地集中在几个方面,
基本的,炎症相关的蛋白质系统,调节
免疫可见性、组织边界、细胞大小和表型
靶向肾小管上皮及其相关的成纤维细胞。 来
在过去几年中,他们的工作可以提炼出来,
跟踪到四个关键领域:一个领域是确定如何
MHCII类基因在肾小管上皮中受到调节;第二个区域
已经确定了IV型胶原基因是如何被调节的,
基底膜重塑;第三个领域是了解
肾小管肥大的分子机制以及细胞如何增大
可能影响致肾炎抗原的表达;第四,
该领域一直致力于开发抗体和分子探针,
专门用于鉴定肾小管间质成纤维细胞。 这些
四个项目主题共同连接了遗传学和
生物化学与基础病理生理学,以便更好地辨别主要
导致间质组织异常结构变化的过程。
研究人员的实验依赖于体外和体内
技术,以组装一个全面的数据库,
主题;这些技术包括使用细胞培养,
放射免疫分析,cDNA克隆,嵌合报告基因,凝胶
阻滞试验,DNA足迹法,转基因替代,欧洲
转染和反义抑制。 他们相信他们的方法,
他们的分析水平将导致更好地理解
体细胞对免疫事件的关键反应可能提供新的
关于形成合理战略的见解,
间质损伤的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ERIC Grant NEILSON其他文献
ERIC Grant NEILSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ERIC Grant NEILSON', 18)}}的其他基金
MOLECULAR REGULATION OF COLLAGEN SWITCHING IN GLOMERULAR BASEMENT MEMBRANE
肾小球基底膜中胶原蛋白转换的分子调控
- 批准号:
6600444 - 财政年份:2002
- 资助金额:
$ 17.18万 - 项目类别:
MOLECULAR REGULATION OF COLLAGEN SWITCHING IN GLOMERULAR BASEMENT MEMBRANE
肾小球基底膜中胶原蛋白转换的分子调控
- 批准号:
6480434 - 财政年份:2001
- 资助金额:
$ 17.18万 - 项目类别:
MOLECULAR REGULATION OF COLLAGEN SWITCHING IN GLOMERULAR BASEMENT MEMBRANE
肾小球基底膜中胶原蛋白转换的分子调控
- 批准号:
6340870 - 财政年份:2000
- 资助金额:
$ 17.18万 - 项目类别:
ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENT
肾脏早期发育中的锌指蛋白
- 批准号:
6201911 - 财政年份:1999
- 资助金额:
$ 17.18万 - 项目类别:
MOLECULAR REGULATION OF COLLAGEN SWITCHING IN GLOMERULAR BASEMENT MEMBRANE
肾小球基底膜中胶原蛋白转换的分子调控
- 批准号:
6201874 - 财政年份:1999
- 资助金额:
$ 17.18万 - 项目类别:
ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENT
肾脏早期发育中的锌指蛋白
- 批准号:
6344795 - 财政年份:1999
- 资助金额:
$ 17.18万 - 项目类别:
MOLECULAR REGULATION OF COLLAGEN SWITCHING IN GLOMERULAR BASEMENT MEMBRANE
肾小球基底膜中胶原蛋白转换的分子调控
- 批准号:
6105525 - 财政年份:1998
- 资助金额:
$ 17.18万 - 项目类别:
ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENT
肾脏早期发育中的锌指蛋白
- 批准号:
6105660 - 财政年份:1998
- 资助金额:
$ 17.18万 - 项目类别:
相似海外基金
Early endothelial function activation by angiotensin II receptor blockers prevents vascular damage in a model of diabetes
血管紧张素 II 受体阻滞剂早期激活内皮功能可预防糖尿病模型中的血管损伤
- 批准号:
493141 - 财政年份:2023
- 资助金额:
$ 17.18万 - 项目类别:
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 17.18万 - 项目类别:
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10707997 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Discovery Grants Program - Individual
Role of Angiotensin II in Bladder Dysfunction
血管紧张素 II 在膀胱功能障碍中的作用
- 批准号:
10555926 - 财政年份:2022
- 资助金额:
$ 17.18万 - 项目类别:
Regulation of nuclear calcium and ROS by Angiotensin II in heart cells. Régulation du calcium et ROS nucléaires par l'angiotensine II dans les cellules cardiaques.
血管紧张素 II 对心脏细胞中核钙和 ROS 的调节。
- 批准号:
RGPIN-2016-04414 - 财政年份:2021
- 资助金额:
$ 17.18万 - 项目类别:
Discovery Grants Program - Individual
Targeting cancer-associated fibroblasts and tumour hypoxia with angiotensin II receptor blockers
使用血管紧张素 II 受体阻滞剂靶向癌症相关成纤维细胞和肿瘤缺氧
- 批准号:
445961 - 财政年份:2021
- 资助金额:
$ 17.18万 - 项目类别:
Operating Grants
Intratubular Angiotensin II and AT1a Receptors in The Proximal Tubules: Roles in Hypertension and Kidney Injury
近曲小管中的管内血管紧张素 II 和 AT1a 受体:在高血压和肾损伤中的作用
- 批准号:
10164776 - 财政年份:2020
- 资助金额:
$ 17.18万 - 项目类别:
Novel Roles of Mitochondrial Angiotensin II in The Proximal Tubule of The Kidney
线粒体血管紧张素 II 在肾近端小管中的新作用
- 批准号:
10251271 - 财政年份:2020
- 资助金额:
$ 17.18万 - 项目类别:
Protection and organ injury by angiotensin II treatment for septic shock
血管紧张素II治疗感染性休克的保护作用和器官损伤
- 批准号:
20K09284 - 财政年份:2020
- 资助金额:
$ 17.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)